Viewing nowCombinationDucanova Tablet 30/2.5 mg (Valsartan, Amlodipine)
Fimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.

MFDS item code 202300130 · Approved 2023.01.06 · Insurance code 694003960
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
This medicine is used in patients with essential hypertension, whose blood pressure is not sufficiently controlled by monotherapy with Valsartan potassium, helping to effectively lower and control blood pressure.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. No initial dose adjustment is required in elderly patients aged 70 years or younger. No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine in pediatric and adolescent patients aged 18 years or younger have not been established.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially during the second and third trimesters; therefore, if pregnancy is confirmed, discontinuation of use should occur immediately. It is safe not to take this medication if there is an allergy to any of the ingredients, if pregnant or breastfeeding, or if the patient has certain conditions such as those undergoing kidney dialysis, severe liver disease, or biliary obstruction. Patients with reduced blood volume or impaired kidney function, renal vascular hypertension patients, patients with severe hypotension, and the elderly should be especially cautious and closely monitored while using this medication. As this medication lowers blood pressure, side effects such as dizziness, headache, edema, urinary disorders, insomnia, and flushing may occur; if symptoms worsen, consult a physician. Patients with hypotension or electrolyte imbalances should correct the condition before taking this medication and continuously monitor blood pressure and electrolyte status during use. Especially for patients with heart failure or kidney impairment, there is a risk of hyperkalemia, so blood potassium levels should be regularly checked. This medication may interact with other antihypertensive drugs, diuretics, potassium-sparing diuretics, and potassium supplements; therefore, if other medications are taken concurrently, it is essential to inform the physician or pharmacist. Pregnant and breastfeeding women are advised to avoid using this drug, and if necessary, should discuss with a physician to find a safe alternative treatment. Safety and efficacy for children and adolescents under 18 years of age have not been established and use is not recommended. Generally, elderly patients do not require dosage adjustment; however, some elderly individuals may be more sensitive to the medication, so caution is necessary. Patients with moderate to severe liver impairment should avoid using this medication and should ensure their liver function condition is well monitored. In case of overdose, severe hypotension, palpitations, and bradycardia can occur; if these symptoms happen, visit a medical institution immediately for appropriate treatment. Store this medication out of the reach of children and avoid transferring it to another container as it may impair its quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that does not allow light to enter. It is also advisable to store the medication at a temperature between 1 and 30 degrees Celsius, which is typically room temperature, to maintain its effectiveness for a longer time.
White, rounded square film-coated tablet
30 tablets / bottle, 300 tablets / bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.